GO:0003183 mitral valve morphogenesis: Developmental Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003183 (mitral valve morphogenesis) describes the biological process that generates and organizes the structure of the mitral valve, the two-leaflet valve separating the left atrium and left ventricle.
• Mitral valve morphogenesis depends on endocardial-to-mesenchymal transition, progenitor cell fate specification, and coordinated signaling through pathways such as PDGFRα and DCHS1.
• Disruption of mitral valve morphogenesis causes congenital and adult valve disease, including mitral valve prolapse, mitral annular disjunction, and mitral annular calcification.
• Key genes include PDGFRα, DCHS1, and progenitor markers identified in mouse cardiac mitral valve development.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate genes in mitral valve morphogenesis.
• Understanding this process informs regenerative strategies and disease modeling for mitral valve disorders.
Description
Mitral valve morphogenesis (GO:0003183) is the developmental process that generates and organizes the structure of the mitral valve, the two-leaflet valve that separates the left atrium from the left ventricle. This process is essential for normal cardiac function, and its disruption leads to congenital and adult-onset mitral valve disease, including mitral valve prolapse and mitral annular calcification. Research into mitral valve morphogenesis has revealed that endocardial cells undergo endothelial-to-mesenchymal transition and contribute to valve leaflet formation, with progenitor populations specified early in development. Signaling pathways involving PDGFRα and the planar cell polarity protein DCHS1 are critical for proper valve remodeling and leaflet organization. Because mitral valve disease is a major cause of morbidity, understanding the molecular and cellular mechanisms of mitral valve morphogenesis is a high-priority area in cardiovascular research.
mitral valve morphogenesis At A Glance
| GO ID | GO:0003183 |
|---|---|
| GO term | mitral valve morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Generation and organization of the mitral valve structure during development |
| Related process | Atrioventricular valve development |
| Key cell type | Endocardial-derived mesenchymal cells and progenitors |
| Key signaling | PDGFRα signaling, DCHS1-mediated planar cell polarity |
| Disease relevance | Mitral valve prolapse, mitral annular calcification, mitral annular disjunction |
What Is GO:0003183?
According to the Gene Ontology, GO:0003183 (mitral valve morphogenesis) is defined as the process in which the structure of the mitral valve is generated and organized. This encompasses the coordinated cellular behaviors, tissue interactions, and signaling events that shape the valve leaflets, annulus, and supporting structures during embryonic development.
Why Is mitral valve morphogenesis Important in Cell Biology?
Mitral valve morphogenesis is critically important because defects in this process underlie a spectrum of mitral valve diseases, from congenital malformations to adult-onset degenerative conditions such as mitral valve prolapse and mitral annular calcification. These conditions affect millions of people worldwide and can lead to heart failure, arrhythmias, and sudden cardiac death. Understanding the molecular and cellular mechanisms of mitral valve morphogenesis provides a foundation for developing targeted therapies and improving clinical outcomes.
• Mitral valve morphogenesis is essential for normal heart function and left-sided cardiac physiology.
• Disruption of this process causes mitral valve prolapse, a common valvular heart disease.
• Mutations in DCHS1 link mitral valve morphogenesis to familial mitral annular disjunction.
• Mitral annular calcification is a degenerative process with developmental origins.
• Progenitor cell fate decisions during mitral valve morphogenesis are critical for leaflet formation.
• PDGFRα signaling is required for proper mitral valve development and remodeling.
• Animal models of mitral valve morphogenesis provide insights into human congenital heart defects.
• CRISPR-based gene editing enables functional validation of candidate genes in valve development.
• Understanding developmental pathways can inform regenerative medicine approaches for valve repair.
• Mitral valve morphogenesis research intersects with lymphatic and cardiac developmental biology.
What Happens During mitral valve morphogenesis?
Endocardial-to-mesenchymal transition and progenitor specification
In simple terms: Cells lining the heart tube change into migratory cells that will build the valve.
During early heart development, a subset of endocardial cells overlying the atrioventricular canal undergo endothelial-to-mesenchymal transition (EndoMT), delaminate, and invade the underlying extracellular matrix to form the endocardial cushions, which are the primordia of the mitral valve. Recent lineage-tracing studies in mouse have identified distinct progenitor populations at the origin of the mitral valve, revealing that cell fate specification occurs before cushion formation and that these progenitors contribute to both leaflets and supporting structures. This step is regulated by signaling pathways including TGF-β/BMP and PDGFRα, which control the timing and extent of EndoMT.
Cushion remodeling and leaflet stratification
In simple terms: The initial valve cushions are sculpted into thin, layered leaflets.
After EndoMT, the endocardial cushions undergo remodeling, a process that involves cell proliferation, apoptosis, and extracellular matrix reorganization to form the stratified leaflets of the mature mitral valve. The valve leaflets become organized into three layers: the fibrosa, spongiosa, and atrialis, each with distinct extracellular matrix composition. PDGFRα signaling has been shown to be essential for this remodeling phase, as loss of PDGFRα function leads to thickened and disorganized leaflets in mouse models. DCHS1, a planar cell polarity protein, also plays a critical role in leaflet organization, and mutations in DCHS1 cause mitral valve prolapse in humans.
Annulus formation and valve support
In simple terms: The ring of tissue that holds the valve in place is formed.
The mitral annulus, a fibrous ring that anchors the valve leaflets and separates the left atrium from the left ventricle, is formed during later stages of mitral valve morphogenesis. This process involves the differentiation of mesenchymal cells into fibrous tissue and the integration of the annulus with the myocardium. Abnormalities in annulus formation can lead to mitral annular disjunction, a condition characterized by separation of the annulus from the ventricular myocardium, which has been linked to mutations in DCHS1. Mitral annular calcification, a degenerative process, also involves the annulus and may have developmental origins.
Valve maturation and functional integration
In simple terms: The valve becomes fully functional and integrated with the heart.
The final stages of mitral valve morphogenesis involve maturation of the valve leaflets and chordae tendineae, which connect the valve to the papillary muscles, ensuring proper coaptation and prevention of regurgitation. This maturation process requires coordinated signaling between the valve endocardium, myocardium, and extracellular matrix. Studies in mouse models have shown that disruption of PDGFRα signaling leads to impaired valve maturation and function. Additionally, cardiac lymphatics have been implicated in normal heart development and may influence valve morphogenesis through tissue fluid homeostasis.
Key Genes Involved in GO:0003183 mitral valve morphogenesis
The following genes and proteins have been experimentally implicated in mitral valve morphogenesis and related valve disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDGFRα | Signaling receptor required for EndoMT and cushion remodeling | Knockout leads to valve defects; target for functional studies |
| DCHS1 | Planar cell polarity protein involved in leaflet organization | Mutations cause mitral valve prolapse and annular disjunction |
| TGF-β/BMP pathway components | Regulate EndoMT and cushion formation | Broad role in valve development |
| Endocardial progenitors (markers) | Cell fate specification at mitral valve origin | Lineage tracing and single-cell studies |
| Vimentin | Mesenchymal marker during EndoMT | Used to identify transformed cells |
| N-cadherin | Cell adhesion molecule in EndoMT | Marker of mesenchymal transition |
| Snail/Slug | Transcription factors inducing EndoMT | Regulate valve progenitor delamination |
| Periostin | Extracellular matrix protein in valve remodeling | Marker of valve interstitial cells |
| Versican | Proteoglycan in cushion matrix | Essential for cushion expansion |
| Hyaluronan | Extracellular matrix component in cushions | Regulates cell migration |
| Notch1 | Signaling in endocardial cells | Regulates EndoMT and valve development |
| NFATc1 | Transcription factor in valve remodeling | Required for valve elongation |
| Sox9 | Transcription factor in valve progenitors | Regulates chondrogenic-like programs |
| Wnt/β-catenin | Signaling in valve interstitial cells | Controls leaflet stratification |
| VEGF | Angiogenic factor in valve development | Influences cushion vascularization |
| Angiopoietin | Vascular remodeling factor | Potential role in valve maturation |
| Cardiac lymphatic markers (e.g., PROX1) | Lymphatic development | May influence valve morphogenesis |
How Is mitral valve morphogenesis Regulated?
Mitral valve morphogenesis is regulated by a complex interplay of signaling pathways, including PDGFRα, TGF-β/BMP, Notch, Wnt, and planar cell polarity pathways. PDGFRα signaling is required for proper EndoMT and cushion remodeling, and its expression is tightly controlled during development. DCHS1, a component of the planar cell polarity pathway, regulates leaflet organization and annulus formation, and its mutations cause mitral valve prolapse. Additionally, cardiac lymphatics and their signaling may modulate the valvular microenvironment during development. Transcriptional regulation by factors such as NFATc1, Sox9, and Snail/Slug further controls cell fate decisions and extracellular matrix remodeling.
mitral valve morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DCHS1 | Mitral valve prolapse, mitral annular disjunction | Knock-in mouse with DCHS1 mutation |
| PDGFRα | Valve malformation, impaired EndoMT | Conditional knockout mouse |
| TGF-β/BMP pathway genes | Congenital valve defects | Zebrafish or mouse knockout |
| Notch1 | Valve dysplasia | Endothelial-specific knockout |
| Unknown (progenitor genes) | Mitral valve developmental defects | Lineage tracing and single-cell RNA-seq |
Mitral valve prolapse and mitral annular disjunction
Mitral valve prolapse (MVP) is a common valvular heart disease characterized by bulging of one or both mitral leaflets into the left atrium during systole. Mutations in DCHS1 were identified as a cause of familial MVP, linking planar cell polarity signaling to mitral valve morphogenesis. A subsequent study found that DCHS1 mutations can also cause familial mitral annular disjunction, a condition where the mitral annulus separates from the ventricular myocardium, further implicating developmental defects in disease pathogenesis.
Mitral annular calcification
Mitral annular calcification (MAC) is a degenerative condition characterized by calcium deposition in the mitral annulus, leading to valve dysfunction. Although traditionally considered a degenerative disease of aging, emerging evidence suggests that developmental processes and genetic factors may contribute to MAC pathogenesis. The presence of calcification in the mitral valve was recognized as early as 1946, and recent studies have explored mechanisms linking developmental signaling to calcification.
Congenital mitral valve anomalies
Congenital mitral valve anomalies, including mitral stenosis and parachute mitral valve, arise from disrupted mitral valve morphogenesis. These defects often occur in conjunction with other congenital heart defects and can be caused by mutations in genes regulating EndoMT and valve remodeling. Understanding the developmental origins of these anomalies is essential for improving diagnosis and treatment.
From mitral valve morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PDGFRα cause mitral valve defects? | PDGFRα knockout mouse |
| Does DCHS1 mutation lead to mitral valve prolapse? | DCHS1 knock-in mouse |
| What is the fate of mitral valve progenitors? | Lineage tracing in mouse |
| Can a candidate gene drive EndoMT? | Overexpression in endocardial cells |
| Does a point mutation in DCHS1 cause annular disjunction? | Point-mutation knock-in mouse |
| What signaling pathways regulate cushion remodeling? | Conditional knockout of TGF-β/BMP receptors |
How to Study the mitral valve morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Progenitor cell fate | Identifying mitral valve origins |
| Single-cell RNA-seq | Transcriptional profiles | Discovering progenitor markers |
| Immunofluorescence | Protein localization | Visualizing EndoMT markers |
| Histology | Tissue architecture | Assessing leaflet stratification |
| CRISPR knockout | Gene function loss | Testing candidate genes in mice |
| CRISPR knock-in | Point mutations | Modeling DCHS1 mutations |
| Overexpression | Gain-of-function | Testing signaling pathways |
| Bioinformatics | Pathway enrichment | Analyzing omics data |
Lineage tracing and single-cell transcriptomics
Lineage tracing using Cre-lox systems in mice allows researchers to follow the fate of endocardial progenitors during mitral valve morphogenesis. Single-cell RNA sequencing can identify distinct progenitor populations and their differentiation trajectories, revealing novel markers and regulatory networks.
Histology and immunofluorescence
Histological staining (e.g., H&E, Movat pentachrome) and immunofluorescence for markers such as N-cadherin, vimentin, and periostin are used to visualize valve structure and cellular transitions during morphogenesis. These methods can reveal defects in leaflet stratification and extracellular matrix organization.
Genetic manipulation in animal models
Knockout, knock-in, and conditional alleles in mice and zebrafish are powerful tools to test gene function in mitral valve morphogenesis. For example, Pdgfra knockout mice exhibit valve defects, and Dchs1 mutant mice recapitulate features of mitral valve prolapse.
CRISPR-based screening and validation
CRISPR knockout and activation screens in cell culture or organoids can identify novel regulators of EndoMT and valve development. Candidate genes can then be validated in vivo using CRISPR-engineered animal models.
How CRISPR Can Be Used to Study GO:0003183 mitral valve morphogenesis
Knockout
CRISPR knockout of candidate genes such as Pdgfra or Dchs1 in mouse models can recapitulate mitral valve morphogenesis defects, providing causal evidence for their roles. Knockout studies have shown that loss of PDGFRα signaling leads to impaired EndoMT and valve malformation.
Point Mutation
CRISPR-mediated point mutations can model specific human variants, such as those in DCHS1 associated with mitral valve prolapse and annular disjunction. These models allow researchers to study the functional impact of disease-associated alleles in vivo.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags into endogenous loci enables visualization and tracking of valve progenitor cells during morphogenesis. This approach can also be used to introduce human disease mutations into the mouse genome.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to test gain-of-function effects of signaling molecules such as PDGFRα or DCHS1 on mitral valve development. Overexpression models help determine whether increased pathway activity is sufficient to drive morphogenetic changes.
How EDITGENE Supports mitral valve morphogenesis Research
Researchers studying mitral valve morphogenesis-related genes often need to determine whether a candidate gene is causally involved in valve development or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for mitral valve morphogenesis research.
Frequently Asked Questions About mitral valve morphogenesis
What is GO:0003183?
GO:0003183 is the Gene Ontology term for mitral valve morphogenesis, the biological process that generates and organizes the structure of the mitral valve.
What genes are involved in mitral valve morphogenesis?
Key genes include PDGFRα, DCHS1, and various TGF-β/BMP and Notch pathway components.
What diseases are associated with defective mitral valve morphogenesis?
Defects can lead to mitral valve prolapse, mitral annular disjunction, mitral annular calcification, and congenital mitral valve anomalies.
How is mitral valve morphogenesis studied?
It is studied using animal models, lineage tracing, single-cell RNA-seq, histology, and CRISPR-based gene editing.
What is the role of PDGFRα in mitral valve morphogenesis?
PDGFRα signaling is required for endothelial-to-mesenchymal transition and cushion remodeling during valve development.
What is DCHS1 and how does it relate to mitral valve disease?
DCHS1 is a planar cell polarity protein; mutations in DCHS1 cause mitral valve prolapse and mitral annular disjunction.
Can CRISPR be used to study mitral valve morphogenesis?
Yes, CRISPR knockout, knock-in, and point mutation models are valuable for testing gene function in valve development.
What are the stages of mitral valve morphogenesis?
Key stages include EndoMT, cushion remodeling, leaflet stratification, annulus formation, and valve maturation.
What cell types are involved in mitral valve morphogenesis?
Endocardial cells, mesenchymal progenitors, and valve interstitial cells are the main cell types.
Why is mitral valve morphogenesis important for heart function?
Proper morphogenesis ensures a functional mitral valve that prevents backflow of blood from the left ventricle to the left atrium.
Conclusion
Mitral valve morphogenesis (GO:0003183) is a complex developmental process essential for normal cardiac function. Research over the past decades has identified critical signaling pathways and genes, including PDGFRα and DCHS1, that regulate endocardial-to-mesenchymal transition, cushion remodeling, and leaflet organization. Disruption of these processes leads to common and clinically significant mitral valve diseases, such as mitral valve prolapse and mitral annular calcification. Continued investigation using advanced CRISPR models and single-cell technologies will further elucidate the mechanisms of mitral valve morphogenesis and inform therapeutic strategies.
References
- 1. Moore K et al.. 2021. PDGFRα: Expression and Function during Mitral Valve Morphogenesis.. J Cardiovasc Dev Dis 8(3) PMID: 33805717
- 2. Massera D et al.. 2020. Mechanisms of mitral annular calcification.. Trends Cardiovasc Med 30(5):289-295 PMID: 31402089
- 3. Farhat B et al.. 2024. Understanding the cell fate and behavior of progenitors at the origin of the mouse cardiac mitral valve.. Dev Cell 59(3):339-350.e4 PMID: 38198889
- 4. de Vlaming A et al.. 2012. Atrioventricular valve development: new perspectives on an old theme.. Differentiation 84(1):103-16 PMID: 22579502
- 5. FERTMAN MH et al.. 1946. Calcification of the mitral valve.. Am Heart J 31:580-9 PMID: 20981944
- 6. Zhou N et al.. 2024. Mutation in mitral valve prolapse susceptible gene DCHS1 causes familial mitral annular disjunction.. J Med Genet 61(2):125-131 PMID: 37399314
- 7. Durst R et al.. 2015. Mutations in DCHS1 cause mitral valve prolapse.. Nature 525(7567):109-13 PMID: 26258302
- 8. Ware SA et al.. 2026. Normal cardiac lymphatics and their mimics.. Am J Physiol Heart Circ Physiol 330(1):H170-H186 PMID: 41285409
